Welcome to our dedicated page for Corvel SEC filings (Ticker: CRVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how CorVel Corporation converts advanced analytics into lower claim costs is vital, yet the company’s SEC paperwork is a maze of healthcare billing codes, captive insurance structures, and network contracting jargon. If you have ever searched “What does CorVel report in its 10-K?” or tried to locate a single footnote on network revenue in a 300-page filing, you know the challenge. Stock Titan resolves that frustration by layering AI-driven language models on top of every disclosure, turning raw documents into plain-English takeaways you can scan in seconds.
Open the CorVel annual report 10-K simplified to see segment profitability, risk factors, and how the CareMC platform scales. Need the latest CorVel quarterly earnings report 10-Q filing? We post it within minutes of hitting EDGAR and attach side-by-side KPI trends. Material updates, such as new managed-care contracts or Medicare set-aside rulings, appear under CorVel 8-K material events explained. Our dashboard also streams CorVel insider trading Form 4 transactions and CorVel executive stock transactions Form 4 so you can watch ownership shifts in real time and cross-check details in the CorVel proxy statement executive compensation section.
Whether you’re benchmarking medical cost containment peers or simply want CorVel SEC filings explained simply, Stock Titan’s tools help you:
- Spot margin shifts with CorVel earnings report filing analysis.
- Receive CorVel Form 4 insider transactions real-time on any device.
- Compare claim volume trends across regions without reading every exhibit.
- Understand complex reimbursement tables with AI-powered summaries.
All filings update automatically, and every paragraph links back to the source so analysts, insurers, and portfolio managers can trust the detail while saving hours. Understanding CorVel SEC documents with AI no longer requires a legal background—just open the page and let the insights surface.
CorVel Corporation (CRVL) insider disclosure shows a proposed sale of 900 common shares through Morgan Stanley Smith Barney on 08/19/2025 with an aggregate market value of $80,251.02. The filer reports acquiring the 900 shares via a stock option exercise on 08/19/2025 and paying in cash. The filing also lists a prior sale of 900 shares by the same person on 05/27/2025 that generated $102,002.58 in gross proceeds. The company has 51,312,748 shares outstanding, so the proposed sale represents a de minimis fraction of total shares. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
CorVel Corporation held its 2025 Annual Meeting of Stockholders on August 7, 2025. At the record date there were 51,440,930 shares outstanding. Six director nominees were elected to serve until 2026, with individual "For" votes ranging from 40,028,742 to 47,158,201 and broker non-votes of 1,630,174 reported for each director.
Shareholders also ratified the appointment of Haskell & White LLP as the independent registered public accounting firm by a vote of 48,879,993 For, 149,755 Against and 11,900 Abstain. The company’s 2025 Stock Incentive Plan was approved with 39,814,198 For, 7,566,390 Against, 30,886 Abstain and 1,630,174 broker non-votes.
Michael Jeffrey J, identified as a director and 10% owner of CorVel Corp (CRVL), was granted 1,500 non-qualified stock options on 08/07/2025 with an exercise price of $85.56. The options expire on 08/07/2035 and become exercisable in four equal annual installments beginning 12 months after the grant, so vesting begins on 08/07/2026. The Form 4 reports the reporting person directly beneficially owns 1,500 derivative securities following the transaction. The filing is signed on 08/11/2025.
CorVel Corp. (CRVL) director Jessup R. Judd was granted 1,500 non-qualified stock options on 08/07/2025 with an exercise price of $85.56. The award represents the right to acquire 1,500 shares of common stock and is reported as direct beneficial ownership.
The options vest in four equal annual installments beginning 12 months after the grant (first vesting about 08/07/2026) and expire on 08/07/2035. The Form 4 records the acquisition (code A) of these derivative securities and shows 1,500 derivative securities owned following the transaction.
Steven Hamerslag, a director of CorVel Corp (CRVL), was granted a non-qualified stock option to purchase 1,500 shares at an exercise price of $85.56. The option is exercisable in four equal annual installments beginning 12 months after the grant date and expires on 08/07/2035.
Following the reported transaction the filing shows beneficial ownership of 1,500 shares on a direct basis. The filing records the grant terms and the vesting schedule but does not disclose total dilution, percentage ownership, or any cash proceeds received.
CorVel Corp director Joanna M. Burkey was granted a non-qualified stock option on 08/07/2025 to purchase 1,500 shares of common stock at an exercise price of $85.56. The option is exercisable in a series of four equal annual installments commencing 12 months after the grant and expires on 08/07/2035. The reported position is held directly and the Form 4 was filed by an agent on behalf of Ms. Burkey and signed on 08/11/2025. No other transactions or cash sales are shown in this filing.
Alan Hoops, a director of CorVel Corp (CRVL), reported insider transactions executed on 08/07/2025. He sold a total of 2,000 common shares (500 sold directly and 1,500 sold indirectly via an irrevocable trust) at $88.58 per share, leaving him with 24,192 shares held directly and 113,713 shares held indirectly, for a combined beneficial ownership of 137,905 shares.
He also received a non-qualified stock option covering 1,500 shares with an exercise price of $85.56, exercisable in four equal annual installments beginning 12 months after the grant and expiring on 08/07/2035. The filing documents the change in holdings and the option grant without additional explanatory detail.
CorVel Corp. (CRVL) Form 4 filing dated 07/23/2025 reports insider activity by Jeffrey J. Michael, a Director and 10% owner.
- Option exercise: Michael exercised 9,000 non-qualified stock options at an exercise price of $11.053 per share (Transaction Code M).
- Tax withholding: 1,066 shares were withheld at $93.28 per share to cover taxes (Transaction Code F).
- Net share change: After the transactions, Michael’s direct holdings increased by 7,934 shares to 559,721 common shares.
- The option grant vests in four equal annual installments beginning 12 months after the grant date; this exercise exhausted the reported option grant, leaving 0 derivative securities outstanding.
No other classes of securities or derivative transactions were disclosed. The filing reflects continued insider ownership concentration.
FAQ
What is the current stock price of Corvel (CRVL)?
What is the market cap of Corvel (CRVL)?
